Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

Maarten Beekman, MD

Advertisement

Articles by Maarten Beekman, MD

Silent (R)evolution in Medical Affairs Through the Power of Partnerships and Collaborations

ByAlexander Bedenkov, MD, PhD,Andrey Ipatov, MD,Filip Surmont, MD,Carmen Moreno,Maarten Beekman, MD,Ryan Bate
October 11th 2019

Pharmaceutical Executive

A look at how Medical Affairs is transitioning to a new and fundamental strategic role within pharma and ways MA can step up to own this role within a pharma company, particularly within emerging markets.

Advertisement

Latest Updated Articles

  • Silent (R)evolution in Medical Affairs Through the Power of Partnerships and Collaborations
    Silent (R)evolution in Medical Affairs Through the Power of Partnerships and Collaborations

    October 11th 2019



Advertisement
Advertisement

Trending on PharmExec

1

How New Technologies Are Impacting the Vaccine Market

2

Deepening Ties: Why China is Becoming Big Pharma's Most Essential R&D Partner

3

Pharmaceutical Executive Daily: Kardigan Sets Terms for $350 Million IPO

4

The Future for Disease Modifying Therapies for Lysosomal Disorders

5

Zepzelca Fails to Meet Main Goal of ‌Phase III Lagoon Trial in Second-Line Small Cell Lung Cancer

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us